Food can lift mood by affecting mood-regulating neurocircuits via a serotonergic mechanism

NeuroImage

Volumn 84, Issue , 2014, Pages 825-832

  Kroes, Marijn C W ^a   van Wingen, Guido A ^a,b   Wittwer, Jonas ^c   Mohajeri, M Hasan ^c   Kloek, Joris ^d   Fernández, Guillén ^a,e  

^a RADBOUD UNIVERSITY   (Netherlands)

^b UNIVERSITY OF AMSTERDAM   (Netherlands)

^c DSM NUTRITIONAL PRODUCTS LTD   (Switzerland)

^d DSM FOOD SPECIALTIES   (Netherlands)

^e RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

FMRI; Food; Long neutral amino acids; Mood; Serotonin; Tryptophan

Indexed keywords

AMINO ACID; PLACEBO; TRYPTOPHAN;

ADULT; ARTICLE; BRAIN REGION; CAUDATE NUCLEUS; CONTROLLED STUDY; FEAR; FEMALE; FOOD INTAKE; FUNCTIONAL MAGNETIC RESONANCE IMAGING; HUMAN; HUMAN EXPERIMENT; LATERAL PREFRONTAL CORTEX; MOOD; NERVE POTENTIAL; NEUROMODULATION; NORMAL HUMAN; POSTERIOR CINGULATE; PREFRONTAL CORTEX; PRIORITY JOURNAL; RESTING STATE NETWORK; REWARD; SEROTONINERGIC SYSTEM; VENTROMEDIAL PREFRONTAL CORTEX;

FMRI; FOOD; LONG-NEUTRAL-AMINO-ACIDS; MOOD; SEROTONIN; TRYPTOPHAN;

ADOLESCENT; ADULT; AFFECT; AMINO ACIDS, NEUTRAL; BRAIN; CROSS-OVER STUDIES; DOUBLE-BLIND METHOD; FEMALE; FOOD; HUMANS; IMAGE PROCESSING, COMPUTER-ASSISTED; MAGNETIC RESONANCE IMAGING; QUESTIONNAIRES; SEROTONIN; TRYPTOPHAN; YOUNG ADULT;

EID: 84885829081     PISSN: 10538119     EISSN: 10959572     Source Type: Journal    
DOI: 10.1016/j.neuroimage.2013.09.041     Document Type: Article

References (53)

1. Abler B., Gron G., Hartmann A., Metzger C., Walter M. Modulation of frontostriatal interaction aligns with reduced primary reward processing under serotonergic drugs. J. Neurosci. 2012, 32:1329-1335.
2. Anand A., Li Y., Wang Y., Gardner K., Lowe M.J. Reciprocal effects of antidepressant treatment on activity and connectivity of the mood regulating circuit: an fMRI study. J. Neuropsychiatry Clin. Neurosci. 2007, 19:274-282.
3. Bigos K.L., Pollock B.G., Aizenstein H.J., Fisher P.M., Bies R.R., Hariri A.R. Acute 5-HT reuptake blockade potentiates human amygdala reactivity. Neuropsychopharmacology 2008, 33:3221-3225.
4. Bishop S.J. Neural mechanisms underlying selective attention to threat. Ann. N. Y. Acad. Sci. 2008, 1129:141-152.
5. Canli T., Congdon E., Todd Constable R., Lesch K.P. Additive effects of serotonin transporter and tryptophan hydroxylase-2 gene variation on neural correlates of affective processing. Biol. Psychol. 2008, 79:118-125.
6. Cools R., Nakamura K., Daw N.D. Serotonin and dopamine: unifying affective, activational, and decision functions. Neuropsychopharmacology 2011, 36:98-113.
7. Crockett M.J., Clark L., Roiser J.P., Robinson O.J., Cools R., Chase H.W., den Ouden H., Apergis-Schoute A., Campbell-Meikeljohn D., Seymour B., Sahakian B.J., Rogers R.D., Robbins T.W. Converging evidence for central 5-HT effects in acute tryptophan depletion. Mol. Psychiatry 2012, 17:121-123.
8. Curran S.L., Andrykowski M.A., Studts J.L. Short Form of the Profile of Mood States (POMS-SF): psychometric information. Psychol. Assess. 1995, 7:80-83.
9. Del-Ben C.M., Deakin J.F.W., McKie S., Delvai N.A., Williams S.R., Elliott R., Dolan M., Anderson I.M. The effect of citalopram pretreatment on neuronal responses to neuropsychological tasks in normal volunteers: an fMRI study. Neuropsychopharmacology 2005, 30:1724-1734.
10. Delgado M.R., Nearing K.I., Ledoux J., Phelps E.A. Neural circuitry underlying the regulation of conditioned fear and its relation to extinction. Neuron 2008, 59:829-838.
11. Derbyshire S. Exploring the pain "neuromatrix". Curr. Pain Headache Rep. 2000, 4:467-477.
12. Di Simplicio M., Norbury R., Reinecke A., Harmer C.J. Paradoxical effects of short-term antidepressant treatment in fMRI emotional processing models in volunteers with high neuroticism. Psychol. Med. FirstView 2013, 1-12.
13. Fox M.D., Snyder A.Z., Vincent J.L., Corbetta M., van Essen D.C. The human brain is intrinsically organized into dynamic, anticorrelated functional networks. Proc. Natl. Acad. Sci. U. S. A. 2005, 102:9673-9678.
14. Fox M.D., Zhang D., Snyder A.Z., Raichle M.E. The global signal and observed anticorrelated resting state brain networks. J. Neurophysiol. 2009, 101:3270-3283.
15. Grahn J.A., Parkinson J.A., Owen A.M. The cognitive functions of the caudate nucleus. Prog. Neurobiol. 2008, 86:141-155.
16. Haber S.N., Knutson B. The reward circuit: linking primate anatomy and human imaging. Neuropsychopharmacology 2009, 35:4-26.
17. Hamer M., Owen G., Kloek J. The role of functional foods in the psychobiology of health and disease. Nutr. Res. Rev. 2005, 18:77-88.
18. Hariri A.R., Mattay V.S., Tessitore A., Fera F., William G., Smith B.S., Weinberger D.R., Weinberger D.R. Dextroamphetamine modulates the response of the human amygdala. Neuropsychopharmacology 2002, 27:1036-1040.
19. Heinz A., Braus D.F., Smolka M.N., Wrase J., Puls I., Hermann D., Klein S., Grüsser S.M., Flor H., Schumann G., Mann K., Büchel C. Amygdala-prefrontal coupling depends on a genetic variation of the serotonin transporter. Nat. Neurosci. 2005, 8:20-21.
20. Heller A.S., Johnstone T., Shackman A.J., Light S.N., Peterson M.J., Kolden G.G., Kalin N.H., Davidson R.J. Reduced capacity to sustain positive emotion in major depression reflects diminished maintenance of fronto-striatal brain activation. Proc. Natl. Acad. Sci. U. S. A. 2009, 106:22445-22450.
21. Kilts C.D., Schweitzer J.B., Quinn C.K., Gross R.E., Faber T.L., Muhammad F., Ely T.D., Hoffman J.M., Drexler K.P.G. Neural activity related to drug craving in cocaine addiction. Arch. Gen. Psychiatry 2001, 58:334-341.
22. Knutson B., Adams C.M., Fong G.W., Hommer D. Anticipation of increasing monetary reward selectively recruits nucleus accumbens. J. Neurosci. 2001, 21:159-164.
23. Kumari V., ffytche D.H., Das M., Wilson G.D., Goswami S., Sharma T. Neuroticism and brain responses to anticipatory fear. Behav. Neurosci. 2007, 121:643-652.
24. Macoveanu J., Rowe J.B., Hornboll B., Elliott R., Paulson O.B., Knudsen G.M., Siebner H.R. Playing it safe but losing anyway-serotonergic signaling of negative outcomes in dorsomedial prefrontal cortex in the context of risk-aversion. Eur. Neuropsychopharmacol. 2012.
25. Markus C. Dietary amino acids and brain serotonin function; implications for stress-related affective changes. Neruomol. Med. 2008, 10:247-258.
26. Markus C., Firk C., Gerhardt C., Kloek J., Smolders G. Effect of different tryptophan sources on amino acids availability to the brain and mood in healthy volunteers. Psychopharmacology 2008, 201:107-114.
27. McCabe C., Mishor Z. Antidepressant medications reduce subcortical-cortical resting-state functional connectivity in healthy volunteers. NeuroImage 2011, 57:1317-1323.
28. McCabe C., Cowen P.J., Harmer C.J. Neural representation of reward in recovered depressed patients. Psychopharmacology 2009, 205:667-677.
29. McCabe C., Mishor Z., Cowen P.J., Harmer C.J. Diminished neural processing of aversive and rewarding stimuli during selective serotonin reuptake inhibitor treatment. Biol. Psychiatry 2010, 67:439-445.
30. McCabe C., Harwood J., Brouwer S., Harmer C., Cowen P. Effects of pramipexole on the processing of rewarding and aversive taste stimuli. Psychopharmacology 2013, 228:283-290.
31. Murphy K., Birn R.M., Handwerker D.A., Jones T.B., Bandettini P.A. The impact of global signal regression on resting state correlations: are anti-correlated networks introduced?. NeuroImage 2009, 44:893-905.
32. Ochsner K.N., Gross J.J. The cognitive control of emotion. Trends Cogn. Sci. 2005, 9:242-249.
33. Pezawas L., Meyer-Lindenberg A., Drabant E.M., Verchinski B.A., Munoz K.E., Kolachana B.S., Egan M.F., Mattay V.S., Hariri A.R., Weinberger D.R. 5-HTTLPR polymorphism impacts human cingulate-amygdala interactions: a genetic susceptibility mechanism for depression. Nat. Neurosci. 2005, 8:828-834.
34. Pizzagalli D.A., Holmes A.J., Dillon D.G., Goetz E.L., Birk J.L., Bogdan R., Dougherty D.D., Iosifescu D.V., Rauch S.L., Fava M. Reduced caudate and nucleus accumbens response to rewards in unmedicated individuals with major depressive disorder. Am. J. Psychiatry 2009, 166:702-710.
35. Price J.L., Drevets W.C. Neurocircuitry of mood disorders. Neuropsychopharmacology 2009, 35:192-216.
36. Rawlings N., Norbury R., Cowen P., Harmer C.J. A single dose of mirtazapine modulates neural responses to emotional faces in healthy people. Psychopharmacology 2010, 212:625-634.
37. Regulation (EC) No 178/2002 Official Journal of the European Communities 2002.
38. Ressler K.J., Mayberg H.S. Targeting abnormal neural circuits in mood and anxiety disorders: from the laboratory to the clinic. Nat. Neurosci. 2007, 10:1116-1124.
39. Robinson T.E., Berridge K.C. The neural basis of drug craving: an incentive-sensitization theory of addiction. Brain Res. Rev. 1993, 18:247-291.
40. Roiser J.P., Levy J., Fromm S.J., Wang H., Hasler G., Sahakian B.J., Drevets W.C. The effect of acute tryptophan depletion on the neural correlates of emotional processing in healthy volunteers. Neuropsychopharmacology 2007, 33:1992-2006.
41. Saper C.B., Chou T.C., Elmquist J.K. The need to feed: homeostatic and hedonic control of eating. Neuron 2002, 36:199-211.
42. Shacham S. A shortened version of the Profile of Mood States. J. Personal Assess. 1983, 47:305-306.
43. Shackman A.J., Salomons T.V., Slagter H.A., Fox A.S., Winter J.J., Davidson R.J. The integration of negative affect, pain and cognitive control in the cingulate cortex. Nat. Rev. Neurosci. 2011, 12:154-167.
44. Spielberger C., Gorsuch R.L., Lushene R., Vagg P.R., Jacobs G.A. Manual for the State-trait Anxiety Scale 1983, Consulting Psychologists Press, Palo Alto, CA.
45. Stathis P., Panourias I., Themistocleous M., Sakas D. Connections of the basal ganglia with the limbic system: implications for neuromodulation therapies of anxiety and affective disorders. Acta Neurochir. Suppl. 2007, 97:575-586.
46. Tanaka S.C., Shishida K., Schweighofer N., Okamoto Y., Yamawaki S., Doya K. Serotonin affects association of aversive outcomes to past actions. J. Neurosci. 2009, 29:15669-15674.
47. van Veen J.F., van Vliet I.M., de Rijk R.H., van Pelt J., Mertens B., Fekkes D., Zitman F.G. Tryptophan depletion affects the autonomic stress response in generalized social anxiety disorder. Psychoneuroendocrinology 2009, 34:1590-1594.
48. Vizi E.S., Zsilla G., Caron M.G., Kiss J.P. Uptake and release of norepinephrine by serotonergic terminals in norepinephrine transporter knock-out mice: implications for the action of selective serotonin reuptake inhibitors. J. Neurosci. 2004, 24:7888-7894.
49. Vogt B.A., Vogt L., Farber N.B., Bush G. Architecture and neurocytology of monkey cingulate gyrus. J. Comp. Neurol. 2005, 485:218-239.
50. Waraich P., Goldner E., Somers J., Hsu L. Prevalence and incidence studies of mood disorders: a systematic review of the literature. Can. J. Psychiatry 2004, 49:124-138.
51. Weissenbacher A., Kasess C., Gerstl F., Lanzenberger R., Moser E., Windischberger C. Correlations and anticorrelations in resting-state functional connectivity MRI: a quantitative comparison of preprocessing strategies. NeuroImage 2009, 47:1408-1416.
52. WHO The World Health Report 2011.
53. Wurtman R.J., Hefti F., Melamed E. Precursor control of neurotransmitter synthesis. Pharmacol. Rev. 1980, 32:315-335.